Abbott Laboratories (ABT) Capital Expenditures (2009 - 2026)
Abbott Laboratories (ABT) posted Capital Expenditures of $497.0 million for Q2 2026, up 24.56% sequentially from $399.0 million in Q1 2026, and down 1.0% YoY from $502.0 million in Q2 2025.
Abbott Laboratories (ABT) Capital Expenditures (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Capital Expenditures for 18 years, with the latest figure at $497.0 million in Q2 2026.
- Quarterly Capital Expenditures fell 1.0% year-over-year to $497.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.1 billion (down 8.0% YoY) and the FY2025 annual result came in at $2.2 billion, down 1.63% from the prior year.
- Capital Expenditures climbed to $497.0 million in Q2 2026 per ABT's latest filing, from $399.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $755.0 million in Q4 2023 and troughed at $321.0 million in Q1 2022.
- A 5-year average of $514.1 million and a median of $499.5 million in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures decreased 19.14% in 2022, then jumped 33.77% in 2023.
- Over 5 years, Capital Expenditures stood at $610.0 million in 2022, then advanced by 23.77% to $755.0 million in 2023, then decreased by 4.64% to $720.0 million in 2024, then declined by 4.31% to $689.0 million in 2025, then dropped by 27.87% to $497.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $497.0 million, $399.0 million, and $689.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 54.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 497.00 Mn |
| Jun 30, 2026 | 497.00 Mn |
| Mar 31, 2026 | 399.00 Mn |
| Mar 31, 2026 | 399.00 Mn |
| Dec 31, 2025 | 689.00 Mn |
| Dec 31, 2025 | 689.00 Mn |
| Sep 30, 2025 | 496.00 Mn |
| Sep 30, 2025 | 496.00 Mn |
| Jun 30, 2025 | 502.00 Mn |
| Jun 30, 2025 | 502.00 Mn |
| Mar 31, 2025 | 484.00 Mn |
| Mar 31, 2025 | 484.00 Mn |
| Dec 31, 2024 | 720.00 Mn |
| Dec 31, 2024 | 720.00 Mn |
| Sep 30, 2024 | 556.00 Mn |
| Sep 30, 2024 | 556.00 Mn |
| Jun 30, 2024 | 533.00 Mn |
| Jun 30, 2024 | 533.00 Mn |
| Mar 31, 2024 | 398.00 Mn |
| Mar 31, 2024 | 398.00 Mn |